Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tolmetin sodium dihydrate, a non-steroidal anti-inflammatory drug (NSAID), is a potent and orally active inhibitor of COX (cyclooxygenase). Its IC 50 values for human COX-1 and COX-2 are 0.35 μM and 0.82 μM, respectively [1] [2].
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 g | ¥ 560 | 35日内发货 | ||
5 g | ¥ 1,980 | 35日内发货 | ||
10 g | ¥ 3,740 | 35日内发货 | ||
25 g | ¥ 7,350 | 35日内发货 |
Tolmetin (sodium salt hydrate) 的其他形式现货产品:
产品描述 | Tolmetin sodium dihydrate, a non-steroidal anti-inflammatory drug (NSAID), is a potent and orally active inhibitor of COX (cyclooxygenase). Its IC 50 values for human COX-1 and COX-2 are 0.35 μM and 0.82 μM, respectively [1] [2]. |
体外活性 | Tolmetin sodium dihydrate (0.25 mM) does not reduce lipid peroxidation in rat brain homogenate. Tolmetin (0.25, 0.5, 0.75, 1 mM) shows radical scavenging properties but without superoxide anion generation in rat brain homogenat [3]. Tolmetin sodium dihydrate (0.001-100 μM) shows anticancer activity againts HT-29 colon cancer cell line in a dose-dependent manner [4]. Tolmetin sodium dihydrate (0-100 μM) shows no effect on osteoblast growth [5]. |
体内活性 | Tolmetin sodium dihydrate (30,100 mg/kg; gavage; single dose or twice daily for 3 and 14 days) exhibits maximal ulcerogenic effect 4 h after the single dose, while potently decreases after 3 and 14 days of repeated administration in male Wistar rats weighing 180-200 g. Tolmetin causes gastric lesions in 100 mg/kg [2]. Tolmetin sodium dihydrate (5 mg/kg twice a day for 5 days) pre-treatment considerably attenuates quinolinic acid (QA)-induced neurotoxicity [3]. |
分子量 | 315.3 |
分子式 | C15H18NNaO5 |
CAS No. | 64490-92-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Tolmetin (sodium salt hydrate) 64490-92-2 sodium Hydrate Tolmetin Inhibitor inhibitor inhibit